Trial Profile
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: Temporary Authorization for Use program in France
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Aug 2015
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 18 Aug 2015 New trial record